Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01282606 · ClinicalTrials.gov registry record · Phase 2
Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation
A Phase 2 study, sponsored by Seikagaku Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 18
- Enrollment target
NCT01282606 is a Phase 2 study that has completed, run by Seikagaku Corporation. The registered enrollment target is 18 participants.
The verdict
NCT01282606, a Phase 2 study, has completed, sponsored by Seikagaku Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety of SI-6603 in lumbar disc herniation patients.
Interventions
- DRUG SI-6603
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01282606
The ClinicalTrials.gov registry entry for NCT01282606 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seikagaku Corporation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SI-6603 is the first listed.
NCT01282606 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01282606 about?
NCT01282606 is a clinical study titled "Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation". The purpose of this study is to evaluate the safety of SI-6603 in lumbar disc herniation patients.
What is the current status of trial NCT01282606?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2007-12.
What interventions are being tested in trial NCT01282606?
The interventions under investigation include: SI-6603 (DRUG).
Who is sponsoring clinical trial NCT01282606?
This trial is sponsored by Seikagaku Corporation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.